Navigating the complexities of neurology drug development requires a steadfast commitment to patient safety and regulatory compliance. AWINSA recently partnered with a US-based biotech firm facing significant pharmacovigilance challenges due to a surge in case volumes and rapid market expansion. By implementing a comprehensive transition plan, AWINSA helped the client streamline their PV processes, clear backlogs, and achieve audit readiness. This successful collaboration enabled the firm to refocus on their core activities, explore new therapeutic opportunities, and maintain the highest standards in patient safety. Dive into our detailed case study to learn more about how AWINSA's expertise made a difference
Copyright © 2024 AWINSA Life Sciences Pvt. Ltd. All rights reserved.
59 E,Shrewsbury Place
Princeton, NJ 08540
United States
E13/9 First floor, Vasant Vihar,
New Delhi 110057
Wilhelmina Druckerlaan 10,
6532 SR,
Nijmegen,
The Netherlands
Cerrada Ahuizotla 53,
Col. Santiago Ahuizotla,
Del. Azcapotzalco
CP.02750
Ciudad de México, México.
